Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32271831.
- Also identified by DOI 10.1371/journal.pone.0231411 and PMC identifier 7145013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Venous thromboembolism (VTE) associated with surgery can cause serious comorbidities or death and imposes a substantial economic burden to society. The study examined VTE cases after surgery to determined how this condition imposed an economic burden on patients based on the national health insurance reimbursement database. Methods: This retrospective analysis adopted the public payer's perspective. The direct medical cost was estimated using data from the national claims database of Vietnam from Jan 1, 2017 to Sep 31, 2018. Adult patients who underwent surgeries were recruited for the study. Patients with a diagnostic code of up to 90 days after surgery were considered VTE cases with the outcome measure being the surgery-related costs within 90 days. The 90-day cost of VTE patients was found to be US$2,939. The rate of readmission increased by 5.4 times, the rate of outpatient visits increased by 1.8 times and total costs over 90 days in patients with VTE undergoing surgery increased by 2.2 times. Estimation using propensity score matching method showed that an increase of US$1,019 in the 90-day cost of VTE patients. The VTE-related costs can be used to assess the potential economic benefit and cost-savings from prevention efforts.
Medical subject headings
- Cost of Illness
- Venous Thromboembolism